COMPANY
TOP MESSAGE
Company Profile
Company Name | Pharma Integrity Inc. |
---|---|
Date of Establishment | March 5, 2019 |
Representative Director | Yoshihiko Otoguro |
Location | Shinjuku Center Building 49F, 1-25-1 Nishi Shinjuku, Shinjuku-ku, Tokyo, Japan |
Our Strength
1. Deep understanding of pharmaceutical businesses
We have a deep understanding of how business is done in the pharmaceutical industry, which is essential to provide effective support for our clients.
All of PhI’s consultants have extensive work experience in the pharmaceutical industry and have a profound understanding of the business.
2. Accumulated know-how about compliance
Our compliance know-how is based on broad industry experience and is definitely helpful for our clients.
3. Extensive experiences in industry associations
Industry associations are very important in the pharmaceutical industry. Reading relevant law texts is not enough to understand the essence of the regulations in the industry.
All of PhI’s consultants have extensive experience in industry associations and have profound practical knowledge about how the regulations are implemented.
4. Expertise on legal norms
Many rules in the pharmaceutical industry are entrusted to self-regulation by industry associations but the ultimate basis for business operations is based on legal norms.
PhI has the expertise of an international lawyer on hand, specializing in the pharmaceutical industry. Our lawyer works as a consultant and has professional knowledge and expertise about legal norms including the current situation and the latest changes and current situation regarding the relevant laws.
5. Close network with external experts
PhI can offer clients a wide range of services with expertise and has the resources to call upon other experts where necessary.
PhI closely cooperates with experts including law firms to resolve complex issues.
MEMBERS
Yoshihiko Otoguro | |
1994 | Glaxo SmithKline KK (“GSK”) (previously Japan Glaxo KK), Academic Department |
---|---|
2003 | GSK, Branch Manager in Kanagawa Prefecture |
2010 | GSK, Head of Business Compliance Department JFTC Headquarters, Administrative Member |
2011 | JPMA Code Compliance Committee, Permanent Member |
2014 | JFTC, Administrative Member at Headquarters |
2015 | EFPIA Japan, Chairman at Corporate Ethics Division |
2016 | Compliance consultant for pharmaceutical companies |
March 2019 | Pharma Integrity Inc., Representative Director |
June 2019 | Advisor for Governance and Legal Committee of EFPIA (The European Federation of Pharmaceutical Industries and Associations) Japan |
Keijiro Minegishi | |
1982 | Japan Glaxo KK, Sales Department |
---|---|
2005 | GSK, Business Compliance Department The Fair Trade Council of the Ethical Pharmaceutical Drugs Marketing Industry |
-Administrative Vice Chairman, Hokkaido Branch -Administrative Vice Chairman, Kita-Kanto Branch -Administrative Vice Chairman, Minami-Kanto Branch -Administrative Member, Tohoku Branch -Administrative Member, Chubu Branch |
|
2010 | Compliance consultant for pharmaceutical companies |
March 2019 | Pharma Integrity Inc., Senior Consultant and Director |
Yohei Kijima | |
2012 | Licensed Lawyer (Tokyo Bar Association) |
---|---|
2013 | Eisai Co., Ltd., Legal Department |
2015 | Licensed Lawyer (New York, USA) |
2017 | CSL Behring KK., Head of Legal and Compliance Department |
January 2019 | Shin-Yotsuya Law Office |
January 2019 | Advisor for the Compliance Research Group of Japan Pharmaceutical Industry Legal Affairs Association (“IHOKEN”) |
March 2019 | Pharma Integrity Inc., Senior Consultant and Director |
April 2021 | GI&T Law Office, LC |
March 2022 | Shin-Yotsuya Law Office |
Executive Adviser
Tokuo Tanaka | |
1983 | Takeda Pharmaceutical Company Limited (“Takeda”) |
---|---|
1993 | Institute for Health Economics and Policy (General Incorporate Foundation), Dispatched Head of Business Planning Department |
2006 | Takeda, Medicine Sales Headquarters, Branch Manager at Kyoto Prefecture |
2010 | Takeda, Medicine Sales Headquarters, Branch Manager at Yokohama Area |
2013 | The Japan Pharmaceutical Manufacturers Association (JPMA), Managing Director |
2014 | MR Education & Accreditation Center of Japan (Public Interest Incorporated Foundation), Director |
2014 | Kyoto Pharmaceutical University (Educational Corporation), Councilor |
2018 | Japan Medical Management Practice Association (General Incorporate Foundation), Director |
2019 | MR Education & Accreditation Center of Japan (Public Interest Incorporated Foundation), Executive Director |
2022 | Academy of Next Generation in Pharmacy (General Incorporate Foundation), Director |
October 2022 | Pharma Integrity Inc., Executive Adviser |
May 2023 | Kyoto Pharmaceutical University (Educational Corporation), Director |